Stay updated on Padsevonil for Drug-Resistant Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Padsevonil for Drug-Resistant Epilepsy Clinical Trial page.

Latest updates to the Padsevonil for Drug-Resistant Epilepsy Clinical Trial page
- Check3 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0 while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check10 days agoChange DetectedA banner announces a transition in NIH terminology from “Artificial Intelligence” to “Super Intelligence.” The study record itself continues to display a 403 error.SummaryDifference1%

- Check17 days agoChange DetectedThe footer revision number changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.SummaryDifference0.2%

- Check24 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check45 days agoChange DetectedPage now displays a 403 Forbidden error instead of the study record, showing a minimal error screen with navigation. The detailed trial content is no longer visible on the page.SummaryDifference17%

- Check66 days agoChange DetectedThe study record now includes an NIH grant/contract note for 2018. The site revision number has been updated to v3.6.6, replacing the prior v3.6.5.SummaryDifference0.0%

Stay in the know with updates to Padsevonil for Drug-Resistant Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Padsevonil for Drug-Resistant Epilepsy Clinical Trial page.